Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy.

Graves' ophthalmopathy (GO) is an autoimmune disorder involving the adipose and connective tissues of the orbit. The study of cytokines present in these tissues may reveal the nature of the cells and immune responses involved in GO pathogenesis. In the current study, we performed relative quantification of the expression of cytokine genes in orbital adipose tissue from patients with GO (n = 6) and normal individuals (n = 2). Real-time RT-PCR was performed using fluorescent probes and primers for cytokines including IL-1 beta, IL-2, IL-4, IL-5, IL-8, IL-10, IFN-gamma, and TNF-alpha. Results showed IL-1 beta to be the gene having the greatest fold expression increase over normal in four of six patients. TNF-alpha was increased in all six GO patients. In addition, IL-8, IL-10, and IFN-gamma were increased in five of six GO patients. We found no evidence of either IL-4 or IL-5 expression in any of the GO or normal samples. The increased expression of the macrophage-derived cytokines IL-1 beta, TNF-alpha, and IL-10 suggests the presence of macrophage activation and ongoing antigen presentation within the orbit in GO. In addition, the overexpression of IFN-gamma, without evidence of IL-4 or IL-5 expression, supports the concept that cell-mediated, rather than humoral, immunity plays the predominant role in pathogenesis of this disorder.

[1]  S. Jyonouchi,et al.  Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy. , 2001, Thyroid : official journal of the American Thyroid Association.

[2]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[3]  M. Prummel,et al.  Both Th1‐ and Th2‐derived cytokines in serum are elevated in Graves' ophthalmopathy , 2000, Clinical and experimental immunology.

[4]  E. Roti,et al.  Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. , 2000, European journal of endocrinology.

[5]  T. Bednarczuk,et al.  Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. , 2000, The Journal of clinical endocrinology and metabolism.

[6]  R. Bahn,et al.  Relationship between disease duration and predominant orbital T cell subset in Graves' ophthalmopathy. , 2000, The Journal of clinical endocrinology and metabolism.

[7]  Förster,et al.  Analysis of orbital T cells in thyroid‐associated ophthalmopathy , 1998, Clinical and experimental immunology.

[8]  P. Fells,et al.  Analysis of extraocular muscle‐infiltrating T cells in thyroid‐associated ophthalmopathy (TAO) , 1997, Clinical and experimental immunology.

[9]  C. Balázs,et al.  High circulating IL-6 level in Graves' ophthalmopathy. , 1997, Autoimmunity.

[10]  R. Bahn,et al.  Cytokines in the evolution of Graves' ophthalmopathy. , 1997, Autoimmunity.

[11]  T. Kuroki,et al.  Human histocompatibility leukocyte antigen-DR and heat shock protein-70 expression in eye muscle tissue in thyroid-associated ophthalmopathy. , 1995, The Journal of clinical endocrinology and metabolism.

[12]  C. Dinarello,et al.  The interleuldn-1 family: 10 years of discovery’ , 2004 .

[13]  H. Dienes,et al.  Immunohistochemical staining of retrobulbar adipose tissue in Graves' ophthalmopathy. , 1994, Clinical immunology and immunopathology.

[14]  W. Holter,et al.  Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts. , 1994, The Journal of clinical investigation.

[15]  M. Prummel,et al.  Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue. , 1994, The Journal of clinical endocrinology and metabolism.

[16]  A. Heufelder,et al.  Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists. , 1994, Investigative ophthalmology & visual science.

[17]  C. Marcocci,et al.  Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. , 1993, The Journal of clinical endocrinology and metabolism.

[18]  Andreas Radbruch,et al.  Regulation of T helper cell cytokine expression: functional dichotomy of antigen‐presenting cells , 1993, European journal of immunology.

[19]  A. Heufelder,et al.  Detection and localization of cytokine immunoreactivity in retro‐ocular connective tissue in Graves' opthalmopathy , 1993, European journal of clinical investigation.

[20]  M P Bevilacqua,et al.  Endothelial-leukocyte adhesion molecules. , 1993, Annual review of immunology.

[21]  K. Matsushima,et al.  Properties of the novel proinflammatory supergene "intercrine" cytokine family. , 1991, Annual review of immunology.

[22]  K. Matsushima,et al.  Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. , 1989, Cytokine.

[23]  P. Fells,et al.  Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. , 1989, Clinical and experimental immunology.

[24]  C. Dinarello Interleukin-1 and its biologically related cytokines. , 1989, Advances in immunology.

[25]  E. Appella,et al.  Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.

[26]  T. Tötterman,et al.  Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease. , 1987, The New England journal of medicine.

[27]  Michael Loran Dustin,et al.  Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). , 1986, Journal of immunology.

[28]  S. Durum,et al.  Interleukin 1: an immunological perspective. , 1985, Annual review of immunology.